India Skin Care Dermacosmetics Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024-2030)
Get a Comprehensive Overview of the India Skin Care Dermacosmetics Market Report Prepared by P&S Intelligence, Segmented by Brand (Skinshine, Cetaphil, Dermadew, Melaglow, Lacto-Calamine, The Derma Co., Venusia, Ahaglow, SkinLite, Dermafique, Neutrogena, Aveeno, Sebamed, BIODERMA), Application (Acne, Dark Circles, Psoriasis, Skin Repair, Wrinkles and Fine Lines, Scars), and Geographic Regions. This Report Provides Insights From 2017 to 2030.
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by brand
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by region
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. India Market
6.1. Overview
6.2. Market Revenue, by Brand (2019–2030)
6.3. Market Revenue, by Application (2019–2030)
Chapter 7. Competitive Landscape
7.1. List of Market Players and their Offerings
7.2. Competitive Benchmarking of Key Players
7.3. Product Benchmarking of Key Players
7.4. Recent Strategic Developments
Chapter 8. Company Profiles
8.1. Emami Group
8.1.1. Business overview
8.1.2. Product and service offerings
8.1.3. Key financial summary
8.2. Cadila Pharmaceuticals Limited
8.2.1. Business overview
8.2.2. Product and service offerings
8.2.3. Key financial summary
8.3. HEGDE & HEGDE PHARMACEUTICA LLP
8.3.1. Business overview
8.3.2. Product and service offerings
8.3.3. Key financial summary
8.4. Piramal Enterprises Limited
8.4.1. Business overview
8.4.2. Product and service offerings
8.4.3. Key financial summary
8.5. Honasa Consumer Limited
8.5.1. Business overview
8.5.2. Product and service offerings
8.5.3. Key financial summary
8.6. Torrent Pharmaceuticals Ltd.
8.6.1. Business overview
8.6.2. Product and service offerings
8.6.3. Key financial summary
8.7. Galderma S.A.
8.7.1. Business overview
8.7.2. Product and service offerings
8.7.3. Key financial summary
8.8. Johnson & Johnson Services Inc.
8.8.1. Business overview
8.8.2. Product and service offerings
8.8.3. Key financial summary
8.9. NAOS
8.9.1. Business overview
8.9.2. Product and service offerings
8.9.3. Key financial summary
8.10. Sebapharma GmbH & Co. KG
8.10.1. Business overview
8.10.2. Product and service offerings
8.10.3. Key financial summary
8.11. NYKAA E-RETAIL LIMITED
8.11.1. Business overview
8.11.2. Product and service offerings
8.11.3. Key financial summary
Chapter 9. Appendix
9.1. Abbreviations
9.2. Sources and References
9.3. Related Reports
